Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression
2024

Targeting BRIX1 to Fight Cancer

publication 10 minutes Evidence: high

Author Information

Author(s): Gan Yu, Hao Qian, Han Tao, Tong Jing, Yan Qingya, Zhong Hongguang, Gao Bo, Li Yanan, Xuan Zhisheng, Li Pengfei, Yao Litong, Xu Yingying, Jiang Yi‐Zhou, Shao Zhi‐Ming, Deng Jun, Chen Jiaxiang, Zhou Xiang

Primary Institution: Fudan University Shanghai Cancer Center

Hypothesis

Can targeting the nucleolar protein BRIX1 suppress cancer progression by inducing nucleolar stress?

Conclusion

Targeting BRIX1 with engineered exosomes can effectively suppress colorectal cancer growth and enhance chemotherapy efficacy.

Supporting Evidence

  • BRIX1 is essential for ribosome biogenesis and cancer cell survival.
  • Depletion of BRIX1 activates the p53 pathway, leading to cancer cell death.
  • Engineered exosomes can effectively deliver siRNA to target BRIX1 in cancer cells.
  • Targeting BRIX1 enhances the efficacy of chemotherapy drugs like 5-FU.

Takeaway

Scientists found that a protein called BRIX1 helps cancer cells grow. By using special tiny bubbles to deliver a message to stop BRIX1, they can make cancer cells weaker and help medicine work better.

Methodology

The study used bioinformatics, cell-based assays, and engineered exosomes to investigate the role of BRIX1 in cancer.

Limitations

The study primarily focused on colorectal cancer and may not generalize to all cancer types.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202407370

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication